Employer Direct Healthcare, a market-leader in the high-performance surgical network and center of excellence space, announced a significant growth investment from Serent Capital, a growth-focused firm that invests in high-growth technology and tech-enabled services companies. The company will continue to focus on scaling its product offerings and provider network to provide cost-efficient healthcare to employers across the U.S.
Founded in 2011, Employer Direct Healthcare (EDH) is a provider of an industry-leading surgical solution, SurgeryPlus®. SurgeryPlus® provides access to top quality and fairly priced care through hundreds of facilities and thousands of surgeons across the U.S. The company’s solution is offered to approximately two million plan members nationwide.
“We are delighted to be partnering with Serent,” said John Zutter, CEO of Employer Direct Healthcare. He continued, “With this investment and Serent’s partnership, we are positioned to further scale our offering and execute on our mission of providing superior quality of care at affordable prices for millions across the U.S.”
“John and the EDH team have built an exceptional solution that provides high-quality, cost-effective solutions to hundreds of large employers,” stated David Kennedy, General Partner at Serent Capital. He continued, “We are excited to partner with EDH to help them grow their go-to-market capabilities through our resources, including our Growth and Human Capital Teams, and our years of healthcare experience.”
Employer Direct Healthcare represents the 8th investment in the healthcare market for Serent Capital and the 2nd investment in the cost containment segment. Previous investments include Axiom Medical, Cardon Outreach, Equinox Healthcare, Pondera, Professional Health Care Network, Senior Dental Care, and United Allergy Services.
About Employer Direct Healthcare and the SurgeryPlus®
Employer Direct Healthcare is a market-leading health care services business providing high-quality and cost-efficient solutions for self-funded employers and their members. The company’s core product, SurgeryPlus®, provides full-service surgical concierge and network services to nearly two million covered members. The company helps members access quality providers, helping employers and their plan participants dramatically reduce surgical costs while providing satisfying outcomes for members.
This publication is for informational purposes only, and nothing contained herein constitutes an offer to sell or a solicitation of an offer to buy any interest in any investment vehicle managed by Serent Capital or any company in which Serent Capital or its affiliates have invested. An offer or solicitation will be made only through a final private placement memorandum, subscription agreement and other related documents with respect to a particular investment opportunity and will be subject to the terms and conditions contained in such documents, including the qualifications necessary to become an investor. Serent Capital does not utilize its website to provide investment or other advice, and nothing contained herein constitutes a comprehensive or complete statement of the matters discussed or the law relating thereto. Information provided reflects Serent Capital’s views as of a particular time and are subject to change without notice. You should obtain relevant and specific professional advice before making any investment decision.
Executive endorsements of Serent Capital are for illustrative purposes, designed to attract business development contacts, and should not be construed as a client or investor testimonial of Serent Capital's investment advisory services. All such endorsements are from current or former portfolio company leadership about Serent Capital’s ability to provide services to their companies. Certain executives are also investors in Serent Capital’s investment vehicle(s), and as such, there is an inherent conflict in that those executives have an incentive to provide favorable reviews of Serent Capital’s business practices for the benefit of the investment vehicles that they hold a personal ownership interest in. Serent Capital has not, directly or indirectly, paid any compensation to such individuals for their endorsements.
Certain information on this Website may contain forward-looking statements, which are subject to risks and uncertainties and speak only as of the date on which they are made. The words “believe”, “expect”, “anticipate”, “optimistic”, “intend”, “aim”, “will” or similar expressions are intended to identify forward-looking statements. Serent Capital undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. Past performance is not indicative of future results; no representation is being made that any investment or transaction will or is likely to achieve profits or losses similar to those achieved in the past, or that significant losses will be avoided.